Christine M. Klaskin

VP, Finance, Agenus.

Companies

AgenusVP, Finance Feb 12, 2008 to now¹
MiNK Therapeutics, Inc.Treasurer Oct 20, 2021 to Oct 20, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

MiNK Therapeutics, Inc. INKT55,660 shares³$555.5K at $9.98Oct 20, 2021
Agenus AGEN23,478 shares⁴$145.2K at $6.18Jun 18, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 18, 2025Granted 15,782 shares at $4.47 of Agenus⁴
Jan 5, 2023Granted 31,294 shares at $2.45 of Agenus⁵
Feb 2, 2022Granted 29,587 shares at $2.51 of Agenus⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAgenus, VP, Finance
2
SEC EDGARMiNK Therapeutics, Inc., Treasurer
3
SEC EDGARMiNK Therapeutics, Inc. shares after the filing of Oct 20, 2021
4
SEC EDGARAgenus shares after the filing of Jun 18, 2025
5
SEC EDGARForm 4 filed Jan 9, 2023
6
SEC EDGARForm 4 filed Feb 4, 2022